GO:0072143 mesangial cell development: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072143 (mesangial cell development) describes the progression of a kidney mesangial cell from its formation to its mature structure.
• Mesangial cells are specialized glomerular stromal cells that provide structural support to the capillary tuft and regulate glomerular filtration.
• Mesangial cell development and homeostasis depend on crosstalk with podocytes and glomerular endothelial cells.
• Dysregulated mesangial cell biology contributes to diabetic nephropathy, lupus nephritis, and other glomerular diseases.
• Key genes implicated in mesangial cell development and disease include GABP, GLI1, and other stromal and immune signaling mediators.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in mesangial cell development.
Description
GO:0072143, mesangial cell development, is a biological process term in the Gene Ontology that defines the progression of a mesangial cell in the kidney over time, from its formation to the mature structure. Mesangial cells are the principal stromal cells of the glomerulus, where they provide structural support to the capillary tuft and contribute to the regulation of glomerular filtration. Understanding this process is essential because mesangial cells are not passive structural elements; they actively participate in glomerular development, homeostasis, and injury responses. The term is therefore central to developmental nephrology and to research on glomerular disease. Experimental evidence has shown that mesangial cell behavior is tightly linked to neighboring podocytes and glomerular endothelial cells, and that disruption of this crosstalk contributes to diabetic kidney disease and other glomerulopathies. Recent single-cell and spatial studies have further highlighted the dynamic interactions between immune and renal cells that control glomerular crescent formation in autoimmune kidney disease, underscoring the importance of mesangial cell development in both normal and pathological contexts. For researchers, GO:0072143 provides a standardized framework for annotating genes and pathways that regulate mesangial cell formation, maturation, and function, enabling reproducible comparisons across studies.
mesangial cell development At A Glance
| GO ID | GO:0072143 |
|---|---|
| GO term | mesangial cell development |
| Ontology | biological_process |
| Synonym | None |
| Definition | The process whose specific outcome is the progression of a mesangial cell in the kidney over time, from its formation to the mature structure. |
| Major function | Formation and maturation of kidney mesangial cells, the glomerular stromal cells that support the capillary tuft and regulate filtration. |
| Related cell types | Mesangial cells, podocytes, glomerular endothelial cells. |
| Associated diseases | Diabetic nephropathy, lupus nephritis, glomerular crescent formation in autoimmune kidney disease. |
| Research methods | Single-cell RNA sequencing, lineage tracing, CRISPR knockout, knock-in, overexpression, and imaging. |
What Is GO:0072143?
In our own words, GO:0072143 (mesangial cell development) is the biological process by which a mesangial cell in the kidney arises and matures over time, progressing from its initial formation to a fully differentiated, mature structure. This term encompasses the cellular and molecular events that establish the mesangial cell as a specialized glomerular stromal cell, including its interactions with adjacent podocytes and endothelial cells, and its acquisition of the structural and functional characteristics required for glomerular support and filtration regulation.
Why Is mesangial cell development Important in Cell Biology?
GO:0072143 is important because mesangial cells are indispensable for glomerular architecture and function, and their developmental failure or dysregulation is linked to major human kidney diseases. Mesangial cells provide mechanical support to the glomerular capillary tuft and modulate filtration surface area, and they are active participants in injury and repair responses. Disrupted mesangial cell biology is a hallmark of diabetic nephropathy, where mesangial expansion and proliferation contribute to fibrosis and loss of renal function. In lupus nephritis, mesangial cells act as a hub for immune complex deposition and inflammatory signaling. Moreover, recent work has shown that spatiotemporal interactions between immune and renal cells, including mesangial cells, control glomerular crescent formation in autoimmune kidney disease, a severe pathological feature. Therefore, understanding the genes and mechanisms that govern mesangial cell development is critical for identifying therapeutic targets and for building accurate disease models.
• Mesangial cells are the glomerular stromal cells that provide structural support to the capillary tuft and regulate filtration.
• GO:0072143 provides a standardized ontology term for annotating genes involved in mesangial cell formation and maturation.
• Dysregulated mesangial cell development and function contribute to diabetic nephropathy and renal fibrosis.
• Mesangial cells are central to the pathogenesis of lupus nephritis, acting as a hub for immune and inflammatory signals.
• Crosstalk among podocytes, glomerular endothelial cells, and mesangial cells is essential for glomerular health and is disrupted in diabetic kidney disease.
• Single-cell transcriptomics has revealed mesangial cell heterogeneity and dynamic interactions with immune cells during glomerular crescent formation.
• Mesangial cell development is a target for regenerative and antifibrotic strategies in kidney disease.
• CRISPR-based models allow causal testing of candidate genes in mesangial cell development and disease.
• Understanding mesangial cell development aids in interpreting kidney organoid and developmental studies.
• GO:0072143 supports reproducible cross-study comparisons in nephrology research.
What Happens During mesangial cell development?
Specification and recruitment of mesangial progenitors
In simple terms: Mesangial cells start as progenitor cells that are specified and recruited to the developing glomerulus.
During kidney development, mesangial cell progenitors are specified and migrate into the glomerular cleft, where they will form the mesangial stalk. This process requires coordinated signaling between the developing glomerular endothelium and surrounding stromal cells. The recruitment of mesangial progenitors is essential for establishing the glomerular architecture, and failure of this step leads to defective glomerular tuft formation. Studies in model organisms have shown that mesangial cells are derived from stromal progenitors that populate the kidney early in development.
Mesangial cell proliferation and expansion
In simple terms: Once recruited, mesangial cells multiply to build the mesangial matrix and support the growing capillary tuft.
After recruitment, mesangial cells proliferate to generate sufficient cell mass for the developing glomerulus. This proliferative phase is tightly regulated by growth factors and transcription factors. For example, GABP promotes mesangial cell proliferation through GLI1 in the context of diabetic nephropathy, indicating that proliferative signaling pathways are active in mesangial cells and can be pathologically reactivated. Normal mesangial development requires a balance between proliferation and differentiation, and dysregulation of this balance contributes to mesangial expansion in disease.
Maturation and acquisition of structural support function
In simple terms: Mesangial cells mature into specialized support cells that hold the glomerular capillaries together.
As mesangial cells mature, they acquire the characteristics of differentiated stromal cells, including the production of extracellular matrix components that form the mesangial matrix. This matrix provides mechanical support to the glomerular capillary loops and helps maintain the filtration surface area. Mature mesangial cells also exhibit contractile properties that contribute to the regulation of glomerular blood flow and filtration. The maturation process involves the expression of specific markers and the establishment of stable interactions with podocytes and endothelial cells.
Crosstalk with podocytes and glomerular endothelial cells
In simple terms: Mesangial cells talk to neighboring podocytes and endothelial cells to keep the glomerulus healthy.
Mesangial cell development is not cell-autonomous; it depends on continuous crosstalk with podocytes and glomerular endothelial cells. This tripartite interaction is essential for glomerular development and homeostasis, and its disruption is a key feature of diabetic kidney disease. Signaling molecules secreted by podocytes and endothelial cells influence mesangial cell behavior, and vice versa. For instance, mesangial cells can modulate endothelial cell function and podocyte survival through paracrine signals. Recent single-cell studies have highlighted the spatiotemporal interaction of immune and renal cells, including mesangial cells, in controlling glomerular crescent formation in autoimmune kidney disease.
Integration into the glomerular tuft and functional maturation
In simple terms: Finally, mesangial cells become fully integrated into the glomerular tuft and start doing their job in filtration.
The final stage of mesangial cell development involves integration into the glomerular tuft, where mesangial cells occupy the central mesangial region and extend processes between capillary loops. This structural integration is necessary for the mesangial cell to perform its roles in supporting the capillary tuft and regulating filtration. Functional maturation includes the ability to respond to vasoactive stimuli and to participate in the regulation of glomerular hemodynamics. Defects in this integration step can lead to glomerular abnormalities and are implicated in developmental kidney disorders.
Key Genes Involved in GO:0072143 mesangial cell development
The following genes and proteins have been experimentally implicated in mesangial cell development, function, or related glomerular biology, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GABP | Promotes mesangial cell proliferation and renal fibrosis through GLI1 in diabetic nephropathy | Target for studying mesangial proliferation in diabetic kidney disease |
| GLI1 | Downstream effector of GABP in mesangial cell proliferation | Mediator of hedgehog signaling in mesangial expansion |
| WT1 | Podocyte transcription factor; crosstalk with mesangial cells | Marker of podocyte-mesangial interaction |
| VEGFA | Endothelial signaling factor influencing mesangial cells | Studied in diabetic kidney disease crosstalk |
| PDGFB | Growth factor involved in mesangial cell proliferation | Classic regulator of mesangial cell biology |
| PDGFRB | Receptor for PDGFB on mesangial cells | Target for mesangial proliferation studies |
| ANGPT2 | Angiopoietin involved in glomerular endothelial-mesangial crosstalk | Implicated in diabetic kidney disease |
| TGFB1 | Profibrotic cytokine driving mesangial matrix expansion | Central to renal fibrosis research |
| CTGF | Downstream of TGFB1; promotes matrix production | Marker of mesangial fibrosis |
| NFKB1 | Inflammatory transcription factor in mesangial cells | Studied in lupus nephritis |
| CCL2 | Chemokine produced by mesangial cells; recruits monocytes | Inflammation mediator in lupus nephritis |
| IL6 | Cytokine secreted by mesangial cells | Inflammatory mediator in glomerular disease |
| COL4A1 | Extracellular matrix component of mesangial matrix | Structural marker of mesangial maturation |
| FN1 | Fibronectin; matrix protein in mesangial expansion | Fibrosis marker in diabetic kidney disease |
| ACTA2 | Smooth muscle actin; contractile marker of mesangial cells | Marker of mesangial cell activation |
| CD34 | Stromal marker used in single-cell studies | Cell identification in glomerular scRNA-seq |
| PECAM1 | Endothelial marker in crosstalk studies | Distinguishes endothelial cells in glomerular models |
How Is mesangial cell development Regulated?
Mesangial cell development is regulated by a network of growth factors, transcription factors, and signaling pathways. PDGFB and its receptor PDGFRB are classic regulators of mesangial cell proliferation and migration during development and in disease. TGFB1 signaling promotes mesangial matrix production and is a key driver of fibrosis in diabetic nephropathy and other glomerulopathies. The GABP-GLI1 axis has been shown to promote mesangial cell proliferation and renal fibrosis in diabetic nephropathy, linking transcriptional regulation to cell cycle progression. Inflammatory signaling through NFKB1 and chemokines such as CCL2 modulates mesangial cell behavior in lupus nephritis. Additionally, crosstalk with podocytes and endothelial cells via factors like VEGFA and ANGPT2 provides external cues that shape mesangial cell development and homeostasis. Single-cell studies have revealed that immune-renal cell interactions dynamically regulate mesangial cell states during crescent formation in autoimmune kidney disease.
mesangial cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GABP | Diabetic nephropathy; mesangial proliferation and fibrosis | Knockout or overexpression in mesangial cell lines and mouse models |
| GLI1 | Diabetic nephropathy; downstream of GABP | Knockdown or pharmacological inhibition in mesangial cells |
| TGFB1 | Renal fibrosis; mesangial matrix expansion | Overexpression or knockout in mesangial cells and kidney organoids |
| CCL2 | Lupus nephritis; monocyte recruitment | Knockout in mesangial cells or lupus-prone mice |
| PDGFB | Mesangial proliferation; developmental glomerular defects | Transgenic overexpression or conditional knockout in mice |
Diabetic nephropathy
Diabetic nephropathy is characterized by mesangial expansion, mesangial cell proliferation, and progressive renal fibrosis. GABP promotes mesangial cell proliferation and renal fibrosis through GLI1 in diabetic nephropathy, identifying a transcriptional axis that could be targeted therapeutically. Crosstalk among podocytes, glomerular endothelial cells, and mesangial cells is disrupted in diabetic kidney disease, contributing to albuminuria and loss of filtration function. Single-cell RNA transcriptomic studies have revealed mechanisms by which mesenchymal stem cell-derived small extracellular vesicles counteract diabetic kidney disease fibrosis, highlighting mesangial cells as a key target.
Lupus nephritis
In lupus nephritis, mesangial cells act as a hub for immune complex deposition, inflammatory cytokine production, and immune cell recruitment. Mesangial cells produce chemokines such as CCL2 and cytokines like IL6, which amplify local inflammation and contribute to glomerular injury. The mesangial cell is therefore a central player in the pathogenesis of lupus nephritis and a potential target for anti-inflammatory therapies.
Autoimmune kidney disease and glomerular crescent formation
Spatiotemporal interactions between immune and renal cells, including mesangial cells, control glomerular crescent formation in autoimmune kidney disease. Recent single-cell and spatial studies have shown that dynamic crosstalk between immune cells and resident glomerular cells drives crescent formation, a severe pathological feature associated with poor renal outcomes. Understanding mesangial cell development and its interaction with immune cells may provide insights into crescentic glomerulonephritis.
Glomerular developmental disorders
Defects in mesangial cell development can lead to abnormal glomerular architecture and function. Mesangial cells are the tuft guys of glomerular development, and their proper formation is essential for establishing a functional glomerular capillary network. Disruption of mesangial cell recruitment or maturation during development may result in glomerular hypoplasia or other structural abnormalities.
From mesangial cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate mesangial cell proliferation? | CRISPR knockout in mesangial cell lines followed by proliferation assays |
| Does a specific point mutation in a gene affect mesangial cell development? | CRISPR point mutation knock-in in mesangial cells or kidney organoids |
| Does overexpression of a gene drive mesangial expansion or fibrosis? | CRISPR-mediated overexpression in mesangial cells and mouse models |
| How does a gene affect crosstalk with podocytes or endothelial cells? | Co-culture models with CRISPR-edited mesangial cells and wild-type podocytes/endothelial cells |
| What is the role of a gene in glomerular crescent formation? | CRISPR knockout in mouse models of autoimmune kidney disease |
| Can a tagged protein be used to track mesangial cell development? | Knock-in of fluorescent or epitope tags at the endogenous locus |
How to Study the mesangial cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA sequencing | Transcriptomic profiles of individual cells | Identifying mesangial cell subtypes and developmental trajectories |
| Lineage tracing | Fate of progenitor cells over time | Tracking mesangial cell origins in kidney development |
| CRISPR knockout | Loss-of-function effects on phenotype | Testing candidate gene requirement in mesangial proliferation |
| CRISPR knock-in | Precise genetic modifications | Introducing point mutations or tags for functional studies |
| Overexpression | Gain-of-function effects | Modeling mesangial expansion and fibrosis |
| Confocal imaging | Spatial distribution of proteins and cells | Visualizing mesangial cell integration in glomeruli |
| Proteomics | Protein expression and modifications | Identifying matrix and signaling changes in disease |
| Co-culture assays | Cell-cell communication | Studying mesangial-podocyte-endothelial crosstalk |
Single-cell RNA sequencing
Single-cell RNA sequencing (scRNA-seq) enables the dissection of mesangial cell heterogeneity and developmental trajectories within the glomerulus. This method has been used to reveal the spatiotemporal interaction of immune and renal cells controlling glomerular crescent formation in autoimmune kidney disease. It is also valuable for identifying mesangial cell-specific markers and for comparing healthy and diseased states.
Lineage tracing and imaging
Lineage tracing using genetic reporters allows researchers to follow the fate of mesangial progenitors during kidney development. Imaging techniques, including confocal and multiphoton microscopy, can visualize mesangial cell integration into the glomerular tuft and their interactions with podocytes and endothelial cells. These approaches are essential for understanding the spatial dynamics of mesangial cell development.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression models are powerful tools for testing the causal role of candidate genes in mesangial cell development. For example, knockout of GABP or GLI1 can be used to assess their requirement for mesangial cell proliferation and fibrosis in diabetic nephropathy. CRISPR screens can also identify novel regulators of mesangial cell differentiation and matrix production.
Proteomics and secretome analysis
Proteomic profiling of mesangial cells and their secreted factors can reveal changes in matrix components and signaling molecules during development and disease. This approach has been used to study the effects of mesenchymal stem cell-derived extracellular vesicles on diabetic kidney disease fibrosis, highlighting mesangial cell responses. Secretome analysis can identify paracrine factors mediating crosstalk with podocytes and endothelial cells.
How CRISPR Can Be Used to Study GO:0072143 mesangial cell development
Knockout
CRISPR knockout is used to delete candidate genes in mesangial cells to determine their requirement for development and function. For instance, knocking out GABP or GLI1 can test their role in mesangial cell proliferation and renal fibrosis in diabetic nephropathy models. Knockout studies in mice have also been used to investigate genes controlling glomerular crescent formation.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific disease-associated mutations into the endogenous locus of mesangial cell genes. This approach is valuable for modeling subtle genetic changes that may affect mesangial cell development or function without completely abolishing protein expression. Point mutations can be used to dissect signaling domains or phosphorylation sites in candidate regulators.
Knock-in
CRISPR knock-in can be used to insert reporter genes, tags, or human disease alleles into mesangial cell genomes. For example, knocking in a fluorescent reporter at a mesangial cell-specific locus enables lineage tracing and live imaging of mesangial cell development. Knock-in of human variants can also create more accurate disease models.
Overexpression
CRISPR-mediated overexpression allows sustained expression of a gene of interest in mesangial cells to model gain-of-function states. Overexpressing profibrotic factors such as TGFB1 or GABP can drive mesangial expansion and matrix production, mimicking features of diabetic nephropathy. This approach is useful for identifying downstream effectors and testing therapeutic interventions.
How EDITGENE Supports mesangial cell development Research
Researchers studying mesangial cell development-related genes often need to determine whether a candidate gene is causally involved in mesangial cell proliferation, maturation, or crosstalk with neighboring glomerular cells. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout and point mutation to knock-in and overexpression, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for mesangial cell development research.
Frequently Asked Questions About mesangial cell development
What is GO:0072143 mesangial cell development?
GO:0072143 is a Gene Ontology biological process term defined as the process whose specific outcome is the progression of a mesangial cell in the kidney over time, from its formation to the mature structure.
What are mesangial cells?
Mesangial cells are specialized glomerular stromal cells that provide structural support to the capillary tuft and regulate glomerular filtration.
What genes are involved in mesangial cell development?
Genes such as GABP, GLI1, PDGFB, PDGFRB, and TGFB1 have been implicated in mesangial cell proliferation, maturation, and fibrosis.
How is mesangial cell development studied?
It is studied using single-cell RNA sequencing, lineage tracing, imaging, and CRISPR-based functional genomics in cell lines and animal models.
Why are mesangial cells important in kidney disease?
Mesangial cell dysfunction contributes to diabetic nephropathy, lupus nephritis, and glomerular crescent formation, making them key targets for therapeutic research.
What is the role of GABP in mesangial cells?
GABP promotes mesangial cell proliferation and renal fibrosis through GLI1 in diabetic nephropathy.
How do mesangial cells interact with podocytes and endothelial cells?
Mesangial cells engage in crosstalk with podocytes and glomerular endothelial cells through paracrine signals, and this interaction is essential for glomerular health and is disrupted in diabetic kidney disease.
Can CRISPR be used to study mesangial cell development?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable causal testing of genes involved in mesangial cell development and disease.
What diseases are associated with mesangial cell development?
Diabetic nephropathy, lupus nephritis, and autoimmune kidney disease with crescent formation are associated with mesangial cell dysfunction.
What methods are used to analyze mesangial cell development?
Single-cell RNA-seq, proteomics, imaging, and CRISPR screens are commonly used to analyze mesangial cell development and function.
Conclusion
GO:0072143 (mesangial cell development) is a fundamental biological process that governs the formation and maturation of mesangial cells, the key stromal cells of the kidney glomerulus. Understanding this process is essential for elucidating the mechanisms of glomerular development and for developing therapies for diabetic nephropathy, lupus nephritis, and other kidney diseases. Advances in single-cell technologies and CRISPR-based models are accelerating the discovery of genes and pathways that control mesangial cell development, offering new opportunities for targeted interventions. Researchers can leverage EDITGENE's comprehensive CRISPR services to functionally validate candidate genes and translate findings into clinically relevant insights.
References
- 1. Du L et al.. 2025. GABP Promotes Mesangial Cell Proliferation and Renal Fibrosis Through GLI1 in Diabetic Nephropathy.. Adv Sci (Weinh) 12(15):e2407462 PMID: 39985381
- 2. Abboud HE. 2012. Mesangial cell biology.. Exp Cell Res 318(9):979-85 PMID: 22414873
- 3. Sultana Z et al.. 2025. Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease.. Nat Immunol 26(11):1977-1988 PMID: 41028563
- 4. Hu S et al.. 2024. Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review.. Cell Commun Signal 22(1):136 PMID: 38374141
- 5. Ji C et al.. 2024. Single-cell RNA transcriptomic reveal the mechanism of MSC derived small extracellular vesicles against DKD fibrosis.. J Nanobiotechnology 22(1):339 PMID: 38890734
- 6. Avraham S et al.. 2021. The Mesangial cell - the glomerular stromal cell.. Nat Rev Nephrol 17(12):855-864 PMID: 34508249
- 7. Liu M et al.. 2022. Mesangial cell: A hub in lupus nephritis.. Front Immunol 13:1063497 PMID: 36591251
- 8. Marciano DK. 2019. Mesangial Cells: The Tuft Guys of Glomerular Development.. J Am Soc Nephrol 30(9):1551-1553 PMID: 31471498
